![Recombinant Anti-CD19 antibody [SP291] - C-terminal (ab227688) | Abcam](https://www.abcam.com/ps/products/227/ab227688/Images/ab227688-10-AntiCD19-antibody-SP291--Cterminal-IHC-human-tonsil.jpg "Recombinant Anti-CD19 antibody [SP291] - C-terminal (ab227688) | Abcam")
Recombinant Anti-CD19 antibody [SP291] - C-terminal (ab227688) | Abcam
Cancers | Free Full-Text | CD19 Chimeric Antigen Receptor-Exosome Targets CD19 Positive B-lineage Acute Lymphocytic Leukemia and Induces Cytotoxicity
85-1240-70 CD19 （B-Lymphocyte Marker） 100ug 930-MSM6-P1ABX 【AXEL】 アズワン
CD19 antibody (PE-65110) | Proteintech
B Cell Overview | Thermo Fisher Scientific - JP
What Is CD19 Antigen? – Creative Biolabs CAR-T Blog
Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains | Nature Biomedical Engineering
Establishing CD19 B-cell reference control materials for comparable and quantitative cytometric expression analysis | PLOS ONE
CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text
Modulation of CD19 surface expression in B cell acute lymphoblastic leukemia | Nature Immunology
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial | Nature Medicine
CD19 antibody (FITC-65110) | Proteintech
Frontiers | Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma
Cells | Free Full-Text | Altered Phenotype and Enhanced Antibody-Producing Ability of Peripheral B Cells in Mice with Cd19-Driven Cre Expression
Overview of CD19-targeted chimeric antigen receptor (CAR)-T-cell... | Download Scientific Diagram
Surface expression of CD19, CD20, CD22, and CD37 in multiple subtypes... | Download Scientific Diagram
CD19 antibody (FITC-65197) | Proteintech
Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models | Science Translational Medicine
A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL: Molecular Therapy
Frontiers | Memory B Cells in Multiple Sclerosis: Emerging Players in Disease Pathogenesis
Molecular analysis of a CD19-negative diffuse large B-cell lymphoma | Haematologica
Modulation of CD19 promoter activity in cHL and B-NHL cell lines. (A)... | Download Scientific Diagram
